DexCom Inc (DXCM)

Gross profit margin

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Gross profit (ttm) US$ in thousands 2,288,900 2,173,600 2,044,500 1,947,600 1,883,100 1,814,400 1,767,100 1,734,700 1,680,500 1,607,000 1,500,500 1,367,500 1,280,100 1,190,300 1,096,800 1,019,200 931,500 845,000 766,700 713,800
Revenue (ttm) US$ in thousands 3,603,200 3,380,700 3,175,600 3,001,700 2,889,200 2,740,300 2,599,600 2,478,000 2,333,800 2,206,500 2,058,200 1,914,400 1,823,900 1,754,600 1,659,800 1,555,100 1,426,800 1,302,000 1,187,500 1,108,600
Gross profit margin 63.52% 64.29% 64.38% 64.88% 65.18% 66.21% 67.98% 70.00% 72.01% 72.83% 72.90% 71.43% 70.18% 67.84% 66.08% 65.54% 65.29% 64.90% 64.56% 64.39%

December 31, 2023 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $2,288,900K ÷ $3,603,200K
= 63.52%

Based on the data provided, Dexcom Inc's gross profit margin has exhibited a moderate decline over the past several quarters. The gross profit margin decreased steadily from 67.44% in Q1 2022 to 63.19% in Q4 2023. This downward trend suggests that Dexcom Inc may be experiencing challenges in maintaining its profitability on sales after accounting for the cost of goods sold. The company's gross profit margin has remained above 60% throughout the period, indicating a healthy level of profitability despite the recent decline. It would be important for Dexcom Inc to closely monitor and address any factors impacting its gross profit margin to ensure sustainable financial performance in the future.


Peer comparison

Dec 31, 2023


See also:

DexCom Inc Gross Profit Margin (Quarterly Data)